Concepedia

Matthew A. Whitman

MA

10

Publications

714

Citations

10

H-Index

2016

Active since

Affiliations

Massachusetts Institute of Technology(Current)

Brigham and Women's Hospital

Harvard University

Cornell University

Dana-Farber Cancer Institute

Matthew A. Whitman is an author at Massachusetts Institute of Technology specializing in medicine, tumor biology, and extracellular matrix.

ORCID

Top concepts

Publications per year

2016–2023

10

Publications

10

Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors

Shawn M. Davidson, Oliver Jonas, Mark A. Keibler et al. · Nature Medicine · 2016 · 326 citations · Full text

, , +8

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes

Spencer S. Watson, Mark Dane, Koei Chin et al. · Cell Systems · 2018 · 99 citations · Full text

, , +17

Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis

Seiji Arai, Oliver Jonas, Matthew A. Whitman et al. · Clinical Cancer Research · 2018 · 68 citations

REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks

Nimrat Chatterjee, Matthew A. Whitman, Cynthia Harris et al. · Proceedings of the National Academy of Sciences · 2020 · 53 citations · Full text

Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer

Siyoung Choi, Matthew A. Whitman, Nicole D. Sempertegui et al. · Nature Biomedical Engineering · 2023 · 39 citations

, , +13

Rows per page

1–5 of 10